Lisata Therapeutics CEO David Mazzo on ASCEND and iLSTA trial results

By Proactive Investors / January 23, 2025 / www.youtube.com / Article Link

Lisata Therapeutics Inc (NASDAQ:LSTA) CEO David Mazzo joined Proactive's Stephen Gunnion with an update on the company's ...

Recent News

Gold stocks rise but lag broader equity gains

January 20, 2025 / www.canadianminingreport.com

Wesdome, Seabridge and Skeena report outstanding drill results

January 20, 2025 / www.canadianminingreport.com

Smaller juniors still financed even in more cautious market

January 13, 2025 / www.canadianminingreport.com

Gold stocks shrug off equity market decline on metal gain

January 13, 2025 / www.canadianminingreport.com

Geopolitical risk outlook unclear after US election

January 06, 2025 / www.canadianminingreport.com

See all >